Abstract
42 cases of male breast cancer were studied. The disease is diagnosed in males at a later stage than in females. The prognosis of this disease in males is more favorable than in females: in stage I there is an 83% 5-year survival, while in stage II there is 62% 5-year survival. Male breast cancer shows a high hormone dependency: 80% of patients arc improved following orchiectomy and 64% following stilbestrol therapy. Data is reported regarding age, family status, community origin, histology, treatment and survival.
| Original language | English |
|---|---|
| Pages (from-to) | 181-189 |
| Number of pages | 9 |
| Journal | Oncology (Switzerland) |
| Volume | 29 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1974 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Male breast cancer
- Mastectomy
- Orchiectomy
- Radiation therapy
- Stilbestrol
Fingerprint
Dive into the research topics of 'Male breast cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver